Top

Published in:

01-08-2020 | Breast Cancer | Reflection

Making Breast Screening Convenient: a Community-Based Breast Screening Event During a Historically Black University’s Homecoming Festivities

Authors: Michelle S. Williams, Catherine Young, Shawn McKinney, Odessa S. Simon Hawkins, Cara Roberson, Chigozie Udemgba, Deirdre B. Rogers, Jimmie Wells, Deborah A. Lake, Dorothy Davis, Tiffanie Young, Deborah Donnell, Barbara J. Herring

Published in: Journal of Cancer Education | Issue 4/2020

Abstract

A breast screening event was conducted during the homecoming festivities of a historically Black university located in a rural county in Mississippi. Two healthcare providers performed clinical breast exams for 26 African American women during the event. This was a prime opportunity to make breast screening accessible for non-elderly African American women.

Guo F, Kuo YF, Shih YCT, Giordano SH, Berenson AB (2018) Trends in breast cancer mortality by stage at diagnosis among young women in the United States. Cancer. 124(17):3500–3509CrossRef

Jemal A, Robbins AS, Lin CC, Flanders WD, DeSantis CE, Ward EM, Freedman RA (2018) Factors that contributed to black-white disparities in survival among nonelderly women with breast cancer between 2004 and 2013. J Clin Oncol 36(1):14–24CrossRef

DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A (2017) Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 67(6):439–448CrossRef

Age-adjusted invasive cancer incidence rates by county in Mississippi, 2012 - 2016. Cancer-Ratesinfo: Mississippi Cancer Registry; 2019

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 109(9):djx030. https://doi.org/10.1093/jnci/djx030

Centers for Disease Control and Prevention (CDC) (2016) Behavioral risk factor surveillance system survey data. Atlanta, Georgia: U.S. Department of Health and Human Services

Bevers TB, Helvie M, Bonaccio E, Calhoun KE, Daly MB, Farrar WB, Garber JE, Gray R, Greenberg CC, Greenup R, Hansen NM, Harris RE, Heerdt AS, Helsten T, Hodgkiss L, Hoyt TL, Huff JG, Jacobs L, Lehman CD, Monsees B, Niell BL, Parker CC, Pearlman M, Philpotts L, Shepardson LB, Smith ML, Stein M, Tumyan L, Williams C, Bergman MA, Kumar R (2018) Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 16(11):1362–1389CrossRef

Mississippi State Department of Health (2015) Mississippi Rural Health Plan. Mississippi State Department of Health, Jackson

Kohler BA, Sherman RL, Howlader N et al (2015) Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst 107(6):djv048CrossRef

10.

Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33(20):2254–2261CrossRef

Title: Making Breast Screening Convenient: a Community-Based Breast Screening Event During a Historically Black University’s Homecoming Festivities
Authors: Michelle S. Williams
Catherine Young
Shawn McKinney
Odessa S. Simon Hawkins
Cara Roberson
Chigozie Udemgba
Deirdre B. Rogers
Jimmie Wells
Deborah A. Lake
Dorothy Davis
Tiffanie Young
Deborah Donnell
Barbara J. Herring
Publication date: 01-08-2020
Publisher: Springer US
Keywords: Breast Cancer
Breast Cancer
Published in: Journal of Cancer Education / Issue 4/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-019-01600-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2020

Awareness of Cancer Risk Factors and Its Signs and Symptoms in Northern Tanzania: a Cross-Sectional Survey in the General Population and in People Living with HIV

20 Years Later: Continued Relevance of Cancer, Culture, and Literacy in Cancer Education for Social Justice and Health Equity

Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers

Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017

Cancer Awareness and Barriers to Medical Treatment Among Syrian Refugees and Lebanese Citizens in Lebanon

Knowledge, Attitude, and Practice Regarding Cancer Screening Tests Among Health Workers in a University Hospital in Turkey

Keynote webinar | Spotlight on antibody–drug conjugates in cancer